Tilray Inc (NASDAQ:TLRY - Get Free Report) traded down 4.9% during mid-day trading on Wednesday . The stock traded as low as $1.73 and last traded at $1.74. 11,608,717 shares changed hands during trading, a decline of 60% from the average session volume of 29,185,414 shares. The stock had previously closed at $1.83.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on the company. Canaccord Genuity Group dropped their target price on Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a research report on Wednesday, April 10th. CIBC lowered their price target on Tilray from $2.25 to $2.00 and set a "neutral" rating on the stock in a report on Wednesday, April 10th. Finally, Alliance Global Partners upped their price target on Tilray from $2.25 to $2.75 and gave the stock a "neutral" rating in a report on Friday, April 5th.
View Our Latest Report on TLRY
Tilray Trading Down 6.0 %
The firm has a market cap of $1.28 billion, a price-to-earnings ratio of -3.91 and a beta of 2.36. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. The business has a fifty day moving average of $1.96 and a two-hundred day moving average of $1.96.
Institutional Investors Weigh In On Tilray
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. HighPoint Advisor Group LLC purchased a new stake in Tilray in the 4th quarter valued at approximately $43,000. Vanguard Group Inc. lifted its stake in Tilray by 7.3% in the 4th quarter. Vanguard Group Inc. now owns 3,407,269 shares of the company's stock valued at $7,837,000 after buying an additional 231,381 shares in the last quarter. Austin Wealth Management LLC purchased a new stake in Tilray in the 4th quarter valued at approximately $115,000. Wellington Wealth Strategies LLC. purchased a new stake in Tilray in the 4th quarter valued at approximately $29,000. Finally, Point72 Asset Management L.P. lifted its stake in Tilray by 35.6% in the 4th quarter. Point72 Asset Management L.P. now owns 2,362,271 shares of the company's stock valued at $5,433,000 after buying an additional 620,700 shares in the last quarter. Hedge funds and other institutional investors own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
